print

Studies

Brown et al. (2000): study AU 1991

Publication

Author(s):
Brown, J.E.; Butow, P.N.; Coates, A.S.; Culjak, G.
Title:
Psychosocial Predictors of Outcome: Time to Relapse and Survival in Patients with Early Stage Melanoma.
Source:
British Journal of Cancer, 2000, Vol. 11, 1448 - 1453

Investigation

Public:
Cancer patients, Sydney Australia, followed 6 years, 1991-1997
Sample:
Non-probability chunk sample
Respondents:
N = 426
Non Response:
21%
Assessment:
Questionnaire: paper
Additional disease data taken from medical records

Happiness Measure(s) and Distributional Findings

Full text:
Self report on single question:

Question on 'mood', full  item not reported
Answer rated on 1 to 100 mm open line scale
1     miserable
:
100 happy
Classification:
A-AOL-?-sq-ol-100-a
Author's label:
Psychosocial predictors
Page in publication:
1448/53
Observed distribution
Frequencies
1: 0%,   2: 0%,   3: 0%,   4: 0%,   5: 0%,   6: 0%,   7: 0%,   8: 0%,   9: 0%,   10: 0%,   11: 0%,   12: 0%,   13: 0%,   14: 0%,   15: 0%,   16: 0%,   17: 0%,   18: 0%,   19: 0%,   20: 0%,   21: 0%,   22: 0%,   23: 0%,   24: 0%,   25: 0%,   26: 0%,   27: 0%,   28: 0%,   29: 0%,   30: 0%,   31: 0%,   32: 0%,   33: 0%,   34: 0%,   35: 0%,   36: 0%,   37: 0%,   38: 0%,   39: 0%,   40: 0%,   41: 0%,   42: 0%,   43: 0%,   44: 0%,   45: 0%,   46: 0%,   47: 0%,   48: 0%,   49: 0%,   50: 0%,   51: 0%,   52: 0%,   53: 0%,   54: 0%,   55: 0%,   56: 0%,   57: 0%,   58: 0%,   59: 0%,   60: 0%,   61: 0%,   62: 0%,   63: 0%,   64: 0%,   65: 0%,   66: 0%,   67: 0%,   68: 0%,   69: 0%,   70: 0%,   71: 0%,   72: 0%,   73: 0%,   74: 0%,   75: 0%,   76: 0%,   77: 0%,   78: 0%,   79: 0%,   80: 0%,   81: 0%,   82: 0%,   83: 0%,   84: 0%,   85: 0%,   86: 0%,   87: 0%,   88: 0%,   89: 0%,   90: 0%,   91: 0%,   92: 0%,   93: 0%,   94: 0%,   95: 0%,   96: 0%,   97: 0%,   98: 0%,   99: 0%,   100: 0%
Summary Statistics
On original range 1 - 100 On range 0-10
Mean:
80.56 8.06
SD:
4.20 0.40

Correlational Findings

Author's label Subject Description Finding Survival time Longevity (assessed in follow up) Relapse Deterioration of health, falling ill